Jeffrey Calabrese - Oct 29, 2021 Form 3 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Vice President of Finance
Signature
s/ John LaRocca, Attorney-in-Fact for Jeffrey Calabrese
Stock symbol
AERI
Transactions as of
Oct 29, 2021
Transactions value $
$0
Form type
3
Date filed
11/8/2021, 03:19 PM
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AERI Common Stock 8.02K Oct 29, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AERI Stock Option (right to buy) Oct 29, 2021 Common Stock 14.4K $33.29 Direct F1
holding AERI Stock Option (right to buy) Oct 29, 2021 Common Stock 7.2K $23.97 Direct F2
holding AERI Stock Option (right to buy) Oct 29, 2021 Common Stock 6.26K $11.02 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, with respect to 25% of the option on June 17, 2020, and monthly in substantially equal installments over the next 36 months thereafter.
F2 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of August 14, 2019.
F3 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of November 1, 2021.